Reference:
Olasnska-Wisniewska A, Olasinski J, Grajek S. Cardiovascular safety of antihistamines. Postepy Dermatol Alergol. 2014;31(3):182-6.
Dávila I, Sastre J, Bartra J, et al. Effect of H1 antihistamines upon the cardiovascular system. J Investig Allergol Clin Immunol. 2006;16.1:13-23.
Pratt C, Brown AM, Rampe D, et al. Cardiovascular safety of fexofenadine HCl. Clin Exp Allergy. 1999;29 Suppl 3:212-6.
Keywords:
ยาแก้แพ้, โรคหัวใจ